Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

NemaGen Discoveries Inc
Profile last edited on: 12/26/2023      CAGE: 8F3F6      UEI: HKYGQCNGSN55

Business Identifier: An early phase biotech company that is focused on advancing therapies to treat allergic inflammation and mast cell-related diseases
Year Founded
2019
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2 Wheatfield Road
Cranbury, NJ 08512
   (855) 217-2557
   N/A
   www.nemagen.com
Location: Single
Congr. District: 12
County: Middlesx

Public Profile

NemaGen Discoveries Inc is a developer of early phase-advancing therapies designed to prevent allergic inflammation and mast-cell diseases. The company's therapies are novel chemical compounds that target Car1 for treating mast cell-related diseases, including mastocytosis, enabling the medical community to effectively combat a diverse range of inflammatory diseases.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$252,094
Phase II Dollars
$0
Total Awarded
$252,094

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 1 NIH $307,094
Project Title: Developing novel therapeutics for the treatment of mastocytosis

Key People / Management

  Jianya Peng

  Mark Siracusa

Company News

There are no news available.